1
|
Rehuman NA, Mathew B, Jat RK, Nicolotti O, Kim H. A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies. Comb Chem High Throughput Screen 2021; 23:898-914. [PMID: 32342809 DOI: 10.2174/1386207323666200428091306] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Revised: 12/30/2019] [Accepted: 01/29/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Monoamine oxidases (MAOs) play a crucial role during the development of various neurodegenerative disorders. There are two MAO isozymes, MAO-A and MAO-B. MAO-A is a flavoenzyme, which binds to the outer mitochondrial membrane and catalyzes the oxidative transformations of neurotransmitters like serotonin, norepinephrine, and dopamine. MATERIALS AND METHODS Focus on synthetic studies has culminated in the preparation of many MAOA inhibitors, and advancements in combinatorial and parallel synthesis have accelerated the developments of synthetic schemes. Here, we provided an overview of the synthetic protocols employed to prepare different classes of MAO-A inhibitors. We classified these inhibitors according to their molecular scaffolds and the synthetic methods used. RESULTS Various synthetic and natural derivatives from a different class of MAO-A inhibitors were reported. CONCLUSION The review provides a valuable tool for the development of a new class of various selective MAO-A inhibitors for the treatment of depression and other anxiety disorders.
Collapse
Affiliation(s)
- Nisha A Rehuman
- Department of Pharmaceutical Chemistry, JJTU University, Jhunjhunu, India
| | - Bijo Mathew
- Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Amrita Health Science Campus, Kochi-682, India
| | - Rakesh K Jat
- Department of Pharmaceutical Chemistry, JJTU University, Jhunjhunu, India
| | - Orazio Nicolotti
- Dipartimento di Farmacia-Scienze del Farmaco, Universita degli Studi di Bari "Aldo Moro", via E. Orabona, 4, I-70125 Bari, Italy
| | - Hoon Kim
- Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Korea
| |
Collapse
|
2
|
Tripathi RKP, Ayyannan SR. Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update. Med Res Rev 2019; 39:1603-1706. [PMID: 30604512 DOI: 10.1002/med.21561] [Citation(s) in RCA: 66] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2018] [Revised: 12/13/2018] [Accepted: 12/15/2018] [Indexed: 12/23/2022]
Abstract
Monoamine oxidase (MAO) inhibitors have made significant contributions and remain an indispensable approach of molecular and mechanistic diversity for the discovery of antineurodegenerative drugs. However, their usage has been hampered by nonselective and/or irreversible action which resulted in drawbacks like liver toxicity, cheese effect, and so forth. Hence, the search for selective MAO inhibitors (MAOIs) has become a substantial focus in current drug discovery. This review summarizes our current understanding on MAO-A/MAO-B including their structure, catalytic mechanism, and biological functions with emphases on the role of MAO-B as a potential therapeutic target for the development of medications treating neurodegenerative disorders. It also highlights the recent developments in the discovery of potential MAO-B inhibitors (MAO-BIs) belonging to diverse chemical scaffolds, arising from intensive chemical-mechanistic and computational studies documented during past 3 years (2015-2018), with emphases on their potency and selectivity. Importantly, readers will gain knowledge of various newly established MAO-BI scaffolds and their development potentials. The comprehensive information provided herein will hopefully accelerate ideas for designing novel selective MAO-BIs with superior activity profiles and critical discussions will inflict more caution in the decision-making process in the MAOIs discovery.
Collapse
Affiliation(s)
- Rati Kailash Prasad Tripathi
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi, India.,Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara, India
| | - Senthil Raja Ayyannan
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi, India
| |
Collapse
|
3
|
Amr AEGE, Hafez NAA, Ali KA, Al-Omar MA, Ghabbour HA. Crystal structure of 1,4-dihydro-1-phenylchromeno[4,3-c]pyrazole, C16H12N2O. Z KRIST-NEW CRYST ST 2016. [DOI: 10.1515/ncrs-2016-0126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
AbstractC16H12N2O, orthorhombic, P212121 (no. 19), a = 5.4475(3) Å, b = 12.2779(7) Å, c = 18.0975(11) Å, V = 1210.43(12) Å3, Z = 4, Rgt(F) = 0.0326, wRref(F2) = 0.0855, T = 100 K.
Collapse
Affiliation(s)
- Abd El-Galil E. Amr
- 1Pharmaceutical Chemistry Department, College of Pharmacy, Drug Exploration and Development Chair (DEDC), King Saud University, Riyadh 11451, Saudi Arabia
- 2Applied Organic Chemistry Department, National Research Centre, Dokki, Giza 12622, Egypt
| | - Naglaa A. Abdel Hafez
- 2Applied Organic Chemistry Department, National Research Centre, Dokki, Giza 12622, Egypt
| | - Korany A. Ali
- 2Applied Organic Chemistry Department, National Research Centre, Dokki, Giza 12622, Egypt
| | - Mohamed A. Al-Omar
- 1Pharmaceutical Chemistry Department, College of Pharmacy, Drug Exploration and Development Chair (DEDC), King Saud University, Riyadh 11451, Saudi Arabia
- 3Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
| | - Hazem A. Ghabbour
- 3Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
- 4Department of Medicial Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura 35516, Egypt
| |
Collapse
|
4
|
Amr AEGE, Hosni HM, Ghabbour HA. Crystal structure of 1,2-bis(4-methoxyphenyl)-2-((3-(trifluoromethyl)phenyl)amino)ethan-1-one, C 23H 20F 3NO 3. Z KRIST-NEW CRYST ST 2016. [DOI: 10.1515/ncrs-2016-0130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
C23H20F3NO3, monoclinic, C2/c (no. 15), a = 48.3041(18) Å, b = 6.0540(2) Å, c = 28.5445(11) Å, β = 105.519(2)°, V = 8043.0(5) Å3, Z = 16, R
gt(F) = 0.056, wR
ref(F
2) = 0.140, T = 293(2) K.
Collapse
Affiliation(s)
- Abd El-Galil E. Amr
- Pharmaceutical Chemistry Department, Drug Exploration and Development Chair (DEDC), College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
- Applied Organic Chemistry Department, National Research Center, Cairo, Dokki 12622, Egypt
| | - Hanaa M. Hosni
- Pesticide Chemistry Department, National Research Center, Dokki 12622, Cairo, Egypt
| | - Hazem A. Ghabbour
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riaydh 11451, Saudi Arabia
- Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
| |
Collapse
|
5
|
Amr AE, Hafez NAA, Ali KA, Al-Omar MA, Ghabbour HA. Synthesis and X-ray study of 6H-chromeno[3,4-e][1,3,4]triazolo[2,3-a]pyrimidine. RUSS J GEN CHEM+ 2016. [DOI: 10.1134/s1070363216080272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
6
|
Amr AE, Mohamed SF, Al-Omar MA, Ghabbour HA. Synthesis, single crystal x-ray analysis, and antimicrobial activity of new (22E)-N'-(4-methoxybenzylidene)-2-[3-cyano-7,8-dihydro-4-(5-methylfuran-2-yl)-2-oxo-2H-pyrano[4,3-b]pyridin-1(5H)-yl]acetohydrazide. RUSS J GEN CHEM+ 2016. [DOI: 10.1134/s1070363216070367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|